1. Home
  2. Analysis
  3. Nicotinic-acid
  4. Revlimid

Nicotinic acid and Revlimid drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Nicotinic acid and Revlimid. Common interactions include spinal compression fracture among females and pneumonia among males.

The phase IV clinical study analyzes what interactions people who take Nicotinic acid and Revlimid have. It is created by eHealthMe based on reports of 69 people who take Nicotinic acid and Revlimid from the FDA, and is updated regularly. You can use the study as a second opinion to make health care decisions.

Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.

On Nov, 30, 2022

69 people who take Nicotinic acid and Revlimid together, and have interactions are studied.

What is Nicotinic acid?

Nicotinic acid has active ingredients of niacin and niacinamide (vitamin b3). It is often used in high blood cholesterol. eHealthMe is studying from 791 Nicotinic acid users for its effectiveness, alternative drugs and more.

What is Revlimid?

Revlimid has active ingredients of lenalidomide. It is often used in multiple myeloma. eHealthMe is studying from 331,425 Revlimid users for its effectiveness, alternative drugs and more.

Number of Nicotinic acid and Revlimid reports submitted per year:

Nicotinic acid and Revlimid drug interactions.

Common Nicotinic Acid and Revlimid drug interactions by gender *:

female:

  1. Spinal compression fracture
  2. Thrombocytopenia
  3. Thrombophlebitis superficial
  4. Thrombosis
  5. Tremor
  6. Vomiting
  7. Back pain
  8. Platelet count decreased
  9. Pneumonia
  10. Pruritus

male:

  1. Pneumonia
  2. Muscle spasms
  3. Platelet count decreased
  4. Rash pruritic
  5. Thrombosis
  6. Asthenia
  7. Atrial flutter
  8. Dizziness
  9. Dyspnoea
  10. Heart rate increased

Common Nicotinic Acid and Revlimid drug interactions by age *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

  1. Thrombosis

50-59:

  1. Pneumonia
  2. Dyspnoea
  3. Rash pruritic
  4. Abscess
  5. Atrial fibrillation
  6. Fatigue
  7. Lacrimation increased
  8. Muscle spasms
  9. Platelet count decreased
  10. Pulmonary thrombosis

60+:

  1. Pneumonia
  2. Muscle spasms
  3. Malaise
  4. Neutropenia
  5. Orthostatic hypotension
  6. Rash
  7. Thrombocytopenia
  8. Thrombosis
  9. Anaemia
  10. Asthenia

Common conditions people have *:

  1. Myelodysplastic Syndrome (a group of conditions that occur when the blood-forming cells in the bone marrow are damaged): 9 people, 13.04%

* Approximation only. Some reports may have incomplete information.

Do you take Nicotinic acid and Revlimid?

Personalize this study to your gender and age

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.

Related studies

Alternative drugs to, pros and cons of the 2 drugs:

Browse all drug interactions of Nicotinic acid and Revlimid:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Common Revlimid side effects:

Browse all side effects of Revlimid:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Common Nicotinic acid interactions:

Browse all interactions between Nicotinic acid and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Common Revlimid interactions:

Browse all interactions between Revlimid and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on niacin and niacinamide (vitamin b3) and lenalidomide (the active ingredients of Nicotinic acid and Revlimid, respectively), and Nicotinic acid and Revlimid (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study. Patients in the study may take other drugs besides Nicotinic acid and Revlimid.

Who is eHealthMe?

With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent studies on eHealthMe:

© 2023 eHealthMe.com. All rights reserved. Use of this site constitutes acceptance of eHealthMe.com's terms of service and privacy policy.